NCT04464772 FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study Status COMPLETED Phase N/A
NCT04444375 Plantar Pain, Balance and Foot Function in Individuals With Diabetes Mellitus Status COMPLETED Phase N/A
NCT04424888 Evaluating Use of Continuous Glucose Monitors in a Short-term 2x2-Crossover Study Status COMPLETED Phase NA
NCT04422145 Hypoglycemia Requiring Emergency Services Intervention: Patient Characteristics, Outcome and Cardiovascular Risk Profile Status COMPLETED Phase NA
NCT04419337 Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke Status UNKNOWN Phase PHASE2
NCT04417270 Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge Status COMPLETED Phase NA
NCT04416204 Effect of High Carbohydrate vs. Low Carbohydrate Diet in Type 2 Diabetes Status COMPLETED Phase NA
NCT04388228 Audit and Feedback for General Practitioners in the Intego Network Status WITHDRAWN Phase NA
NCT04387448 A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease Status TERMINATED Phase PHASE2
NCT04385758 Community Paramedicine Program to Improve Diabetes Care Quality, Equity, and Outcomes Status COMPLETED Phase NA
NCT04379427 Measurement Algorithm Control and Optimization With Subsequent Performance Evaluation of Sanmina Non-invasive Biosensors During a Standardized Meal Test in Patients With Diabetes Mellitus Type 1 and Type 2 Status COMPLETED Phase NA
NCT04374864 Dose Modification Requirement for Trelagliptin in Egyptian Population Status UNKNOWN Phase PHASE4
NCT04371978 Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 Status TERMINATED Phase PHASE3
NCT04369833 Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform Status COMPLETED Phase N/A
NCT04361552 Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection) Status WITHDRAWN Phase PHASE3
NCT04351880 Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge Status COMPLETED Phase NA